CIBC Private Wealth Group
SLNO

CIBC Private Wealth Group’s Soleno Therapeutics SLNO Stock Holding History

CIBC Private Wealth Group’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.87K Buy
+62
New +$3.4K ﹤0.01% 2740
2025
Q3 		– Sell
-3
Closed -$251 – 3289
2025
Q2 		$251 Buy
+3
New +$225 ﹤0.01% 2893

Other funds holding SLNO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CIBC Private Wealth Group's SLNO Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Soleno Therapeutics (SLNO) in Q4 2025: 62 shares worth $2.87K. The stake represents ﹤0.01% of the portfolio and ranks #2740 among its holdings. This is a return to the name: CIBC Private Wealth Group previously reported a position in SLNO as recently as Q2 2025.

CIBC Private Wealth Group first reported a position in SLNO in Q2 2025 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold SLNO as of Q4 2025.

  • CIBC Private Wealth Group held 62 shares of Soleno Therapeutics worth $2.87K as of Q4 2025.
  • Soleno Therapeutics was a new CIBC Private Wealth Group position in Q4 2025.
  • Soleno Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2740 holding.
  • CIBC Private Wealth Group first reported a position in Soleno Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 248 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.